Diagnosing Liver Cancer

About Liver Cancer

At Penn Medicine, patients with liver cancer, or hepatocellular carcinoma (HCC), receive their care from a multidisciplinary team of nationally recognized experts in the diagnosis, treatment and research of gastrointestinal cancer.

The Abramson Cancer Center's interdisciplinary gastrointestinal cancer program was the first of its kind. Its close collaboration with Penn Medicine's transplant program provides access to comprehensive medical and surgical care for patients who require a liver transplant. Penn Transplant Institute has performed more than 1,500 liver transplants.

The liver is the largest solid organ in the body and is located on the right side of the abdomen. The liver is responsible for such functions as filtering the blood for excess toxins, helping regulate blood sugar, creating bile for digestion, and creating enzymes responsible for blood clotting.

There are two main types of liver cancer.

  • Primary liver cancer: Cancer that forms in the tissues of the liver. The most common type is hepatocellular carcinoma (HCC).
  • Secondary liver cancer: Cancer that spreads, or metastasizes, to the liver from another part of the body like the breast, lung, thyroid or other gastrointestinal cancers.

Penn Medicine's multidisciplinary approach to cancer diagnosis and treatment provides better outcomes and gives patients access to the most advanced treatment, surgical techniques and clinical trials.

Because navigating a cancer diagnosis and treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can help them make an appointment with the right physician.

To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN (7366).

Liver Cancer Risk and Prevention

Liver Cancer Risk and Prevention

There are risk factors that can increase the chance of developing liver cancer. Having a risk factor, or even several, does not mean that someone will get cancer. There are different kinds of risk factors. Some factors, like age or race, can't be changed, while other factors can be reduced by changes in lifestyle.

Hepatocellular Carcinoma (HCC) Risk Factors

Primary liver cancer, cancer that does not originate in another part of the body, affects more than 20,000 people in the United States each year, and these numbers are expected to continue to grow.

Risk factors for liver cancer include:

  • Cirrhosis. Cirrhosis is scarring of the liver and poor liver function, resulting from chronic liver disease.  There are several conditions that can cause cirrhosis:
    • Hepatitis C: Infection acquired through needle sticks, IV drug use, or a blood transfusion before 1992
    • Hepatitis B: Infection acquired through sex with an infected partner, IV drug use or, in some countries, mother-to-fetal transmission
    • Hereditary hemochromatosis: Genetic disease that causes excessive amounts of iron to be absorbed by the intestine
    • Alcohol abuse
    • Nonalcoholic steatohepatitis (NASH): Liver inflammation caused by a buildup of fat in the liver; condition is associated with obesity and diabetes
  • Tobacco use: Tobacco use has been shown to increase risk of liver cancer in some people.
  • Aflatoxin: This fungus, found in foods like grains and nuts that are not properly stored, may increase the risk for liver cancer and is associated with HCC in southern Africa.

Liver Cancer Risk Assessment

Patients with cirrhosis of the liver, or those with long standing hepatitis B or C infections, are at risk for developing liver cancer and should speak with their physician about screening options.

Liver Cancer Prevention

There are ways to reduce the risk of liver cancer:

  • Get the hepatitis B vaccine: Preventing hepatitis B infection with the hepatitis B vaccine has shown to lower the risk of liver cancer in children.
  • Eliminate tobacco use. Tobacco use has been linked to an increased risk for developing liver cancer.
  • Practice safe sex. Unprotected sex puts a person at risk for contracting many diseases including hepatitis B and C, which have been shown to increase cancer risk.
  • Don’t use IV drugs. Contaminated needles shared during drug use put people at risk for contracting hepatitis C.
  • Curb alcohol intake. Excessive amounts of alcohol, or alcohol abuse, can increase the risk of cirrhosis, a risk factor for liver cancer.

back to top

Types of Liver Cancer

Types of Liver Cancer

There are two main types of liver cancer.

  • Primary liver cancer
  • Secondary liver cancer

Primary Liver Cancer

Primary liver cancer forms in the tissues of the liver. The most common type is hepatocellular carcinoma (HCC).

Secondary Liver Cancer

Secondary liver cancer is cancer that spreads, or metastasizes, to the liver from another part of the body like the breast, lung, thyroid or other gastrointestinal cancers.

back to top

Liver Cancer Symptoms

Liver Cancer Symptoms

In its earliest stages, liver cancer is typically not associated with any symptoms. As the disease progresses, symptoms may include:

  • Jaundice or yellowing of the skin and eyes
  • Fatigue
  • Weight loss without dieting
  • Loss of appetite
  • Feeling of abdominal fullness or bloating
  • Pain and/or discomfort on the right side of the abdomen
  • Pain or discomfort that occurs in the right shoulder blade

back to top

Staging Liver Cancer

Staging Liver Cancer

Staging systems provide doctors with a common language for describing tumors. After cancer is first diagnosed, a series of tests are used to investigate the extent of the cancer and to see whether it has spread to other parts of the body from where it started. Staging is a way of recording the size and growth of a cancer, and determining the plan for treatment. By understanding the stage of their cancer, patients can make informed decisions about their treatment.

Learn more about how liver cancer is staged using the TNM staging system.

back to top

Liver Cancer Treatment at Penn

Liver Cancer Treatment at Penn

After being diagnosed with liver cancer, patients at the Abramson Cancer Center may be evaluated through the Gastrointestinal Cancer Evaluation Center (GICEC). The center provides patients with expert support and evaluation to discuss treatment options and individualized treatment plans.

ADAM Image

Patients with liver cancer are treated by a multidisciplinary team of cancer specialists who see more patients with gastrointestinal (GI) cancers in one year than many doctors see in their careers. Physicians from gastroenterology, gastrointestinal surgery, radiology and infectious diseases meet weekly in a hepatocellular carcinoma (HCC) clinic to discuss cases.

Penn Medicine’s GI cancer physicians are nationally recognized for their expertise in the diagnosis and treatment of cancer.

Penn’s GI cancer treatment team includes:

  • Nationally recognized medical experts with years of experience in diagnosing and treating GI cancer.
  • Nurses with advanced training and experience in caring for patients with GI cancer.
  • Oncology Navigation Specialists to help patients navigate the health system.
  • Registered dietitians to provide nutrition counseling.
  • Cancer counselors to provide individual or family counseling for the physical and emotional issues many cancer patients face.
  • Rehabilitation therapists who specialize in the diagnosis and treatment of physical effects from cancer and its treatment.

Penn Medicine offers many treatment options including clinical trials for those with liver cancer. In addition to standard treatments, or treatments commonly used, clinical trials are studies meant to help improve current treatments or obtain information about new treatments.

Patients at Penn Medicine can benefit from participating in clinical trials that take place at Penn. Patients interested in learning more about clinical trials should speak with someone on their treatment team.

Penn Transplant Institute

Penn’s GI cancer program also works closely with the liver transplant team at the Penn Transplant Institute.

Patients with liver cancer who are candidates for transplant surgery are cared for by a multidisciplinary team of specialists who manage their care from the first evaluation visit to postoperative care.

Learn more about the liver transplant team at the Penn Transplant Institute.

Patient navigation Specialists

Every step of cancer treatment; from a cancer diagnosis, to surgery and treatment to forming a survivorship plan; comes with different needs and issues that should be addressed.

Oncology Navigation Specialists at the Abramson Cancer Center are available to make a patient’s experience as seamless as possible. As experts in navigating complex health care situations, Oncology Navigation Specialists serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families. They can help in a variety of ways including; provide emotional support, identify resources, and ensure access to information, support services, educational programs and community resources.

Learn more about patient navigation specialists at the Abramson Cancer Center.

back to top

Diagnosing Liver Cancer

An accurate cancer diagnosis from trusted cancer specialists is the first step in getting personalized treatment options to treat liver cancer.

Patients who choose Penn's Abramson Cancer Center, benefit from a multidisciplinary team of cancer specialists including gastroenterologists, radiologists, pathologists and surgeons who work together to provide a diagnosis and treatment plan designed specifically for each patient with liver cancer.

Cancer specialists at Penn Medicine are highly experienced in using the most advanced techniques for diagnosing cancer and are actively researching better and more precise ways to detect liver cancer.

Navigating a cancer diagnosis and treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can help them make an appointment with the right person. Penn Medicine's contact center has experienced cancer nurses available and ready to guide patients in finding the cancer specialist right for them.

To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN (7366).

Screening for Liver Cancer

Screening for Liver Cancer

Liver cancer usually does not cause any symptoms until the cancer is advanced. Currently, there are no approved and recommended screening tests for liver cancer like mammograms for breast cancer or colonoscopies for colon cancer.

One potential screening tool tests the blood for alpha-fetoprotein (AFP). AFP levels can be a marker for the development of liver cancer, but not all liver cancers produce high levels of AFP.

Some studies recommend people at high risk for developing liver cancer may have their AFP levels checked every six months and an abdominal ultrasound performed annually. Screening guidelines should be discussed by patients and their physicians.

back to top

Diagnostic Tools for Liver Cancer

Diagnostic Tools for Liver Cancer

If liver cancer is suspected, Penn Medicine’s team of gastrointestinal cancer physicians guide patients through the diagnostic process that can include:

  • Medical history and physical exam.
  • Imaging tests. Pictures of the inside of the body to help find out whether a suspicious area might be cancerous, to learn how far cancer may have spread, or to determine if treatment is working.
    • Computed tomography (CT). A CT scan creates a 3-D X-ray of the inside of the body. A computer combines the images into a detailed, cross-sectional view that shows any abnormalities or tumors. Sometimes, a contrast medium (dye) is used to provide better detail.
    • Ultrasound. Ultrasounds use sound waves to image an area of the body. This test is painless and does not expose patients to radiation.
    • Magnetic resonance imaging (MRI). Magnetic fields are used to create detailed images of the body. A contrast medium may be injected into a vein to create a clearer picture.
    • Positron emission tomography (PET) scan. A PET scan is a way to create pictures of organs and tissues inside the body. A small amount of a radioactive substance is injected into the patient’s body. The tumor absorbs the radioactive substance at a different rate than normal cells, and a scanner detects the substance to produce images.
    • Angiography. A catheter is threaded along the blood vessels leading to the liver. Contrast is injected into the blood vessels and X-rays are taken that can show highly vascular liver tumors. This procedure is not regularly performed.
  • Laparoscopy. This minimally invasive procedure allows the physician to view the lymph nodes and other organs to see if cancer has spread. Biopsies may be taken of the organ tissue.
  • Biopsy. A sample of the suspicious area is removed and viewed under a microscope. Penn Medicine surgeons perform several different types of biopsies based on the amount of tissue being removed. Some biopsies use a needle, while others require a small surgical procedure to remove more tissue.
  • Lab tests. Lab tests can help a physician diagnose liver cancer, determine current liver function, learn how other organs may be affected, and look for signs of reoccurrence. Some types of lab tests include:
    • Alpha-fetoprotein (AFP) blood test
    • Liver function tests
    • Blood clotting tests
    • Tests for hepatitis
    • Kidney function tests
    • Electrolytes and blood chemistry tests

back to top

Staging Liver Cancer

Staging Liver Cancer

Staging systems provide doctors with a common language for describing tumors. After cancer is first diagnosed, a series of tests are used to investigate the extent of the cancer and to see whether it has spread to other parts of the body from where it started. Staging is a way of recording the size and growth of a cancer, and determining the plan for treatment. By understanding the stage of their cancer, patients can make informed decisions about their treatment.

Liver cancer is most commonly stages using the TNM staging system.

T Stage

The T stage represents the extent of the primary tumor itself.

  • TX: Primary tumor cannot be assessed
  • T0: No evidence of primary tumor
  • T1: Solitary tumor without invasion of blood vessels in the liver (not including major branches of the portal of hepatic vein)
  • T2: Solitary tumor with invasion of blood vessels in the liver (not including major branches of the portal of hepatic vein) OR multiple tumors, none of which are >5 cm in size
  • T3a: Multiple tumors at least one of which is >5 cm in size, OR a tumor that involves a major branch of the portal or hepatic vein
  • T3b: At least one tumor that has grown into a major branch of the large veins of the liver (the portal and hepatic veins)
  • T4: Tumors that directly invade into adjacent organs (not including the gall bladder) OR a tumor that invades the lining of the abdomen

N Stage

The N stage represents the degree of the involvement of the lymph nodes.

  • NX: The regional lymph nodes cannot be assessed
  • N0: No evidence of spread to the lymph node
  • N1: Regional lymph nodes are involved with tumor

M Stage

The M stage represents whether or not there is spread of cancer to other parts of the body.

  • M0: No evidence of distant spread of the cancer
  • M1: Evidence of distant spread of the cancer including spread to non-regional lymph node chains

The “staging diagnosis” combines the T, N and M groups:

  • Stage I: T1, N0, M0: There is a single tumor (any size) that has not grown into any blood vessels. The cancer has not spread to nearby lymph nodes or distant sites.
  • Stage II: T2, N0, M0: Either a single tumor (any size) has grown into blood vessels; OR there are several tumors, and all are less than 5 cm (2 inches) in diameter. The cancer has not spread to nearby lymph nodes or distant sites.
  • Stage IIIA: T3a, N0, M0: There are several tumors, and at least one is larger than 5 cm (2 inches) across. The cancer has not spread to nearby lymph nodes or distant sites.
  • Stage IIIB: T3b, N0, M0: At least one tumor is growing into a branch of the major liver blood vessels (portal vein or hepatic vein). The cancer has not spread to nearby lymph nodes or distant sites.
  • Stage IIIC: T4, N0, M0: A tumor is growing into a nearby organ (other than the gallbladder); OR a tumor has grown into the outer covering of the liver. The cancer has not spread to nearby lymph nodes or distant sites.
  • Stage IVA: Any T, N1, M0: Tumors in the liver can be any size or number and they may have grown into blood vessels or nearby organs. The cancer has invaded nearby lymph nodes. The cancer has not spread to distant sites.
  • Stage IVB: Any T, Any N, M1: The cancer has spread to other parts of the body. (Tumors can be any size or number, and nearby lymph nodes may or may not be involved.)

Physicians at Penn often classify liver cancers by whether or not they can be entirely removed by surgery, or resectable. There are three ways physicians look at liver cancer:

  • Localized resectable cancers: Only a small number of patients with liver cancer have tumors that can be completely removed by surgery. This would include most stage I and some stage II cancers in the TNM system, in patients who do not have cirrhosis.
  • Localized unresectable cancers: Cancers that have not spread to the lymph nodes or distant organs, but cannot be completely removed by surgery are classified as localized unresectable. This would include some early stage cancers, as well as stage IIIA and IIIB cancers in the TNM system.
  • Advanced cancers: Cancers that have spread to lymph nodes or other organs are classified as advanced. These would include stage IIIC and stage IV cancers in the TNM system. Most advanced liver cancers cannot be treated with surgery.

back to top

Liver Cancer Treatment

Following the diagnosis and staging of liver cancer, cancer specialists at Penn's Abramson Cancer Center develop a personalized treatment plan. Penn's treatment options for liver cancer include:

  • Surgery
  • Radiation therapy
    • 3-D conformal radiation therapy
    • Intensity-modulated radiation therapy (IMRT)
    • Volumetric-modulated arc therapy (VMAT)
    • Proton therapy
    • Stereotactic body radiotherapy
  • Chemotherapy
    • Liver-directed therapies
      • Ethanol injection
      • Chemoembolization of the hepatic artery
  • Biologic therapies
  • Other treatments

Because navigating a cancer diagnosis and treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can help them make an appointment with the right physician.

To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN (7366).

Surgery for Liver Cancer

Surgery for Liver Cancer

Penn Medicine has one of the largest gastrointestinal surgical programs in the United States with a nationally recognized record for high-quality patient care and long-term survival.

Partial Hepatectomy

A partial hepatectomy removes the part of the liver where cancer is found. The part removed may be a wedge of tissue, an entire lobe, or a larger portion of the liver, along with some of the healthy tissue around it. The remaining liver tissue takes over the functions of the liver.

Hepatic Lobectomy

A hepatic lobectomy is the surgical removal of a lobe of the liver. The remaining liver tissue takes over the functions of the liver.

Radiofrequency Ablation

Radiofrequency ablation uses a special probe with tiny electrodes that kill cancer cells. Sometimes the probe is inserted directly through the skin and only local anesthesia is needed. In other cases, the probe is inserted through an incision in the abdomen. This is done in the hospital using general anesthesia.

Total Hepatectomy and Liver Transplant

A total hepatectomy and liver transplant removes the entire liver and replaces it with a healthy donated liver. A liver transplant may be done when the cancer is only in the liver and a donor liver is available. If the patient has to wait for a donated liver, other treatment is given as needed.

Liver cancer patients who are candidates for liver transplant benefit from a close collaboration between their physicians within the gastrointestinal cancer program and Penn Medicine’s transplant program. The Penn Transplant Institute provides comprehensive medical and surgical care for patients who require a liver transplant.

Penn Medicine has performed more than 1,500 liver transplants.
The Penn Transplant Institute has an active Living Donor program for patients requiring a liver transplant. The anatomy of the liver allows it to be divided and a portion transplanted into another individual. Using a family member or another person as a source for liver transplantation benefits donors by reducing the waiting time for a transplant and improves the chances of organ survival.

back to top

Radiation Therapy for Liver Cancer

Radiation Therapy for Liver Cancer

Radiation oncologists at Penn Medicine are recognized for techniques that target radiation precisely to the disease site while sparing nearby tissue.

Proton therapy at Penn Medicine will soon be used to treat liver cancer, and is currently used to treat recurrent tumors in the digestive tract. Penn Medicine is one of the only facilities in the country treating gastrointestinal cancers in this way.

Radiation therapy uses high-energy radiation to kill cancer cells. A radiation therapy schedule usually consists of a specific number of treatments given over an extended period of time. In many cases, radiation therapy is capable of killing all of the cancer cells.

3-D Conformal Radiation Therapy

The imaging technology used by radiation oncologists at Penn Medicine helps shape the radiation treatment beam to the shape of the tumor. Conformal radiation therapy gives doctors more control when treating tumors.

Special computers use CT imaging scans to create 3-D maps of the location of the cancer in the body. The system permits the delivery of radiation from several directions, and the beams can then be shaped, or conformed, to match the shape of the cancer. Conformal radiation therapy limits radiation exposure to nearby healthy tissue as well as the tissue in the beam's path.

Intensity-Modulated Radiation Therapy (IMRT)

This advanced type of radiotherapy uses a computer-controlled device, called a linear accelerator, to deliver precise doses of radiation to tumors or specific areas within the tumors. Radiation therapy, including IMRT, stops cancer cells from dividing and growing, thus slowing or stopping tumor growth. In many cases, radiation therapy is capable of killing all of the cancer cells.

Using 4-D computed tomography (CT) images along with computerized dose calculations, IMRT allows for the radiation dose to conform more precisely to the shape of the tumor by controlling, or modulating, the intensity of the radiation beam while tracking any movement of the tumor. The therapy allows higher radiation doses to be delivered to regions within the tumor while minimizing the dose to the surrounding area.

Volumetric-Modulated Arc Therapy (VMAT)

Volumetric modulated arc therapy (VMAT) is a type of specialized intensity modulated radiation therapy. VMAT delivers radiation by rotating the radiation machine, through one or more arcs while radiation is continuously delivered.

VMAT allows Penn radiation oncologists to treat complex cancers while minimizing exposure to surrounding healthy tissue. VMAT shortens radiation delivery time, and offers patient more comfort because it does not require patients to lie completely still for long periods of time.

Penn radiation oncologists use RapidArc™ radiotherapy technology to treat hard to reach tumors.

Proton Therapy

Penn Medicine is the only academic medical center in the country that is using proton therapy to treat recurrent gastrointestinal tumors in clinical trials. Also, radiation oncologists at Penn Medicine will soon use proton therapy to treat liver cancer, one of the only health care centers in the country to do so.

Penn Medicine's Roberts Proton Therapy Center is the largest and most advanced facility in the world for this precise form of cancer radiation. Patients have access to one of the most sophisticated weapons against cancer, seamlessly integrated with the full range of oncology services available at Penn Medicine. Proton therapy is external beam radiotherapy in which protons are directed at a tumor.

The radiation dose that is given through protons is very precise, and limits the exposure of normal tissues. This allows the radiation dose delivered to the tumor to be increased beyond conventional radiation. The result is a better chance for curing cancer with fewer harmful side effects.

Proton therapy, like all forms of radiation therapy, works by aiming the energized particles, in this case protons, onto the target tumor. The particles damage the DNA of cells, ultimately causing their death. Unlike X-rays, protons can be manipulated to release most of their energy only when they reach their target. With more energy reaching the cancerous cells, more damage is administered by each burst of radiation.

Stereotactic Body Radiotherapy

Stereotactic body radiotherapy is a type of stereotactic radiosurgery that uses a linear accelerator to deliver high doses of radiation to a targeted area over a shorter length of time. The precision of stereotactic body radiotherapy allows Penn radiation oncologists to target small tumors, or tumors that are difficult to reach.

back to top

Chemotherapy for Liver Cancer

Chemotherapy for Liver Cancer

Penn Medicine specializes in a team approach to treatment with interdisciplinary care and innovative approaches that use chemotherapy to target tumors prior to surgery. Chemotherapy uses drugs to kill cancer cells. It is delivered through the bloodstream, targeting cancer cells throughout the body.

Liver-directed Therapies

Ethanol Injection
A high concentration of ethanol injected directly into tumor cells can kill the tumor. Only small tumors can be treated in the manner. For patients with a several small tumors, ethanol injections can result in reasonable rates of tumor control.

Chemoembolization of the Hepatic Artery
Injecting an anticancer drug into the hepatic artery that supplies blood to the liver blocks blood flow to the liver and interrupts the blood supply to the tumor.

Biologic Therapies

Tyrosine kinase inhibitors (TKIs) such as sorafenib, may be effective in treating hepatocellular carcinoma by inhibiting tumor-cell proliferation and tumor angiogenesis. Tyrosine kinase is a chemical messenger (enzyme) that plays a part in the growth of cancer cells. Biologic therapies are available as clinical trials.

back to top

Clinical Trials for Liver Cancer

Clinical Trials for Liver Cancer

Clinical trials benefit patients by introducing breakthrough therapies and treatments. These new advances in cancer treatment are occurring every day at Penn Medicine, giving patients hope that even greater discoveries lie ahead. Through clinical trials:

  • Diagnosing cancer has become more precise.
  • Radiation and surgical techniques have advanced.
  • Medications are more successful.
  • Combinations of medical, surgical and radiation therapy are improving treatment effectiveness and enhancing outcomes.
  • Strategies to address the late effects of cancer and its treatment are improving quality of life.

Currently, patients with liver cancer may be candidates for these clinical trials at Penn Medicine:

  • Biologic therapy. Biologic therapy uses the patient's own immune system to fight cancer. Substances made by the body or in a laboratory are used to boost, direct or restore the body's natural defenses against cancer. This type of cancer treatment is also called biotherapy or immunotherapy.
  • Hyperthermia therapy. Hyperthermia therapy exposes the cancer tissue to high temperatures that damage and kill cancer cells, or makes cancer cells more sensitive to the effects of radiation and certain anticancer drugs. Because some cancer cells are more sensitive to heat than normal cells, the cancer cells die and the tumor shrinks.
  • Proton therapy. Penn Medicine is the academic medical center in the country that is using proton therapy to treat recurrent gastrointestinal tumors in clinical trials. Also, radiation oncologists at Penn Medicine will soon use proton therapy to treat gastrointestinal cancers in the upper digestive tract. Also, radiation oncologists at Penn Medicine will soon use proton therapy to treat liver cancer, the only health care center in the country to do so.

Find more liver cancer clinical trials at Penn Medicine.

back to top

Other Treatments for Liver Cancer

Other Treatments for Liver Cancer

In addition to standard treatments and clinical trials, patients at Penn Medicine may wish to add additional therapies and treatments such as massage therapy, acupuncture and art therapy. These therapies do not have curative intent, and are designed to complement standard treatments, not take their place.

Integrative Medicine and Wellness Programs

At Penn Medicine, integrative medicine and wellness services can supplement traditional cancer treatments such as chemotherapy, surgery and radiation therapy. While conventional medicine plays a critical role in eradicating cancer, integrative medicine and wellness programs offer patients and their families ways to enhance the quality of their lives, minimize or reduce the side effects of cancer and cancer treatment, and promote healing and recovery.

Cancer specialists at Penn Medicine are knowledgeable and supportive of complementary cancer treatments. The cancer team works with patients and families to integrate these supportive programs into the overall care plan, while ensuring the safety and health of patients.

The Abramson Cancer Center’s range of integrative supportive services is designed to help patients cope with the cancer experience and improve their overall sense of well-being. Services include:

The Joan Karnell Cancer Center at Pennsylvania Hospital offers a variety of supportive care programs for patients and families, from diagnosis through survivorship. These programs are available at no cost to the patients treated at Pennsylvania Hospital, and some are open to patients treated elsewhere. These services include social work counseling, nutrition counseling, psychological counseling and spiritual counseling.

The Cancer Appetite and Rehabilitation Clinic focuses on patients with loss of appetite and weight.

The Supportive Care Clinic helps to manage cancer related symptoms. Integrative support programs include:

Support groups and educational programs are available at Pennsylvania Hospital throughout the year.

Palliative Care

Palliative care provides medical and non-medical interventions to ease the symptoms of cancer and its treatment. Palliative care includes physical, emotional and spiritual care that can enhance the quality of life for cancer patients.

Palliative care can be used to complement traditional cancer therapies, or to improve quality of life when curative therapies are no longer an option.

Palliative care is an approach to patient care that can be integrated with curative therapies at any point from diagnosis to survivorship or end of life care.

Palliative care services include palliative chemotherapy, radiation therapy and surgery as well as psychological counseling, art therapy and support groups for patients and families. The goals of palliative care are to enhance the quality of life for cancer patients and their families, and provide emotional and spiritual support to enhance personal growth.

Palliative care services are offered at Pennsylvania Hospital, and at the Hospital of the University of Pennsylvania.

Penn Home Care and Hospice Services

Penn Home Care and Hospice Services offer a full range of home health care needs by partnering three top-level home health care services under one roof:

Penn Home Care and Hospice Services offer an array of specialized therapies and medications for patients with cancer and cancer-related conditions.

Patient navigation Specialists

Every step of cancer treatment – from a cancer diagnosis, to surgery and treatment to forming a survivorship plan – comes with different needs and issues that should be addressed.

Oncology Navigation Specialists at the Abramson Cancer Center are available to make a patient’s experience as seamless as possible. As experts in navigating complex health care situations, patient navigation specialists serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families. They can help in a variety of ways including; provide emotional support, identify resources, and ensure access to information, support services, educational programs and community resources.

Learn more about Oncology Navigation Specialists at the Abramson Cancer Center.

back to top

Liver Cancer Survivorship

There are more than 12 million cancer survivors living and thriving today as a result of advances in cancer treatment. However, cancer treatments can result in physical, emotional and financial complications long after the therapy is complete. Survivorship programs at Penn Medicine are a distinct phase of liver cancer care and are designed to help patients transition from their cancer treatment routine to a post-cancer care lifestyle.

Personalized Survivorship Care

Personalized Survivorship Care

Close follow-up care for liver cancer patients is crucial because there is a high rate of recurrence. Routine follow-up care should be performed for several years following treatment.

At the end of treatment, liver cancer patients should schedule a survivorship visit with their oncologist and nurse practitioner. At this time, patients are provided with a summary of the treatment received as well as a plan for follow-up care.

Long-term liver cancer survivors should speak to their oncologist and nurse practitioner about scheduling a one-time survivorship-focused consultation with a nurse practitioner or physician. Annual or more frequent follow-up appointments are also available.

Penn cancer providers work one-on-one with patients to develop survivorship care plans. Since every cancer is unique, the plans are tailored to the patients. 

The survivorship care plan includes information on:

  • Potential long-term or late side effects of cancer treatment, the symptoms and treatment.
  • Recommendations for cancer screening for disease recurrence or a new cancer.
  • Psychosocial effects, including relationships and sexuality.
  • Planning follow-up visits.

A survivorship care plan encourages patients to review the information with their healthcare team and become active participants in their follow-up care.

Patient navigation Specialists

Every step of cancer treatment – from cancer diagnosis, to surgery and treatment to forming a survivorship plan – comes with different needs and issues that should be addressed.

Oncology Navigation Specialists at the Abramson Cancer Center are available to make a patient’s experience as seamless as possible. As experts in navigating complex health care situations, Oncology Navigation Specialists serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families. They can help in a variety of ways including; provide emotional support, identify resources, and ensure access to information, support services, educational programs and community resources.

Learn more about patient navigation specialists at the Abramson Cancer Center.

back to top

Survivorship Programs at Penn Medicine

Survivorship Programs at Penn Medicine

Penn Medicine’s Living Well After Cancer™ Program is a nationally recognized program that focuses on issues facing cancer survivors. In 2007, the Abramson Cancer Center was designated a LIVESTRONG ™ Survivorship Center of Excellence Network.  The Abramson Cancer Center is only one of eight LIVESTRONG centers in the United States, and is the only LIVESTRONG Survivorship Center of Excellence in the Philadelphia region. The program focuses on survivorship, a distinct phase of care.

Prescription for Living: The Cancer Survivorship Program at the Joan Karnell Cancer Center at Pennsylvania Hospital, provides patients with a summary of important information about specific cancer diagnoses and treatments, as well as follow-up information and steps to take towards recovery, supportive care and education to help patients adjust to their lives as cancer survivors.

back to top

Continued Support

Continued Support

Penn offers cancer patients support programs and groups to enhance their survivorship care plans.

The Abramson Cancer Center and Joan Karnell Cancer Center at Pennsylvania Hospital host a wide range of materials and activities that provide education and support to address key areas of concern including survivorship for cancer patients and their loved ones.

Focus On: Gastrointestinal Cancers is a day-long conference for patients and their loved ones that addresses surrounding gastrointestinal cancers.

back to top

Survivor Stories

Suzi F. Garber

Suzi F. Garber, of Reading, PA., a neuroendocrine tumor patient at the Abramson Cancer Center, writes about her experience so that others might benefit from her story and become proactive advocates for themselves and their loved ones.

For many years, I had been misdiagnosed as having irritable bowel syndrome. After I wound up in the emergency ward in intense pain, I had a battery of tests -- I had an ileal bowel obstruction. An octreotide scan showed spots in my liver which was subsequently biopsied and were positive for carcinoid cancer, Stage IV. I had been diagnosed with a rare cancer that both had metastasized and was inoperable at the time.




Spotlight

Stand Up to Cancer

Peter O'Dwyer, MD, professor of Hematology-Oncology and program director of Development Therapeutics in the Abramson Cancer Center, was interviewed on NBC10's 10! Show about Penn's work as part of the Stand Up to Cancer Dream Team... Read more

Liver Cancer Trials

Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery... more